Risk of new-onsetmetabolic syndrome associatedwith white-coat andmasked hypertension: Data froma general population

Journal of Hypertension

Volumn 36, Issue 9, 2018, Pages 1833-1839

  Cuspidi, Cesare ^a,b   Facchetti, Rita ^a   Bombelli, Michele ^a   Sala, Carlac ^c   Tadic, Marijana ^d   Grassi, Guido ^a,e   Mancia, Giuseppe ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e IRCCS MULTIMEDICA   (Italy)

Author keywords

General population; Metabolic syndrome; Office and out of office blood pressure

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MEDICAL HISTORY; METABOLIC SYNDROME X; MIDDLE AGED; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WHITE COAT HYPERTENSION; AGED; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; HYPERTENSION; INCIDENCE; ITALY;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; ITALY; MALE; MASKED HYPERTENSION; METABOLIC SYNDROME; MIDDLE AGED; WHITE COAT HYPERTENSION;

EID: 85049384595     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001767     Document Type: Article

References (27)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Report of the National Cholesterol Education Program (NCEP). Executive Summary: the third report of the national cholesterol education program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:248-2497.
2. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745-2749.
3. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, and all cause in United States adults. Circulation 2004;110:1245-1250.
4. Scuteri A, Franco OH, Völzke H, Shin MH, Kweon SS, et al., Nilsson PM For the MARE Consortium. The relationship between the metabolic syndrome and arterial wall thickness: a mosaic still to be interpreted. Atherosclerosis 2016;255:11-16.
5. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-1357.
6. Hermida RC, Smolensky MH, Ayala DE, Portaluppi F. Ambulatory blood pressure monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults. Chronobiol Int 2015;32:1329-1342.
7. Mancia G, Verdecchia P. Clinical value of ambulatory blood pressure, evidence and limits. Circ Res 2015;116:1034-1045.
8. Shimbo D, Abdalla M, Falzon L, Townsend RR, Muntner P. Role of ambulatory and home blood pressure monitoring in clinical practice: a narrative review. Ann Intern Med 2015;163:691-700.
9. Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension 2002;40:795-796.
10. Mancia G. Clinical significance of white-coat hypertension. J Hypertens 2016;34:623-626.
11. Afsar B. Comparison of demographic, clinical, and laboratory parameters between patients with sustained normotension, white coat hypertension, masked hypertension, and sustained hypertension. J Cardiol 2013;61:222-226.
12. Sivén SS, Niiranen TJ, Kantola IM, Jula AM. White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study. J Hypertens 2016;34:54-60.
13. Asayama K, Sato A, Ohkubo T, Mimura A, Hayashi K, Kikuya M, et al. The association between masked hypertension and waist circumference as an obesity-related anthropometric index for metabolic syndrome: the Ohasama study. Hypertens Res 2009;32:438-443.
14. Vyssoulis G, Karpanou E, Adamopoulos D, Kyvelou SM, Gymnopoulou E, Cokkinos D, Stefanadis C. Nocturnal blood pressure fall and metabolic syndrome score in patients with white coat hypertension. Blood Press Monit 2008;13:251-256.
15. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana GC, Zanchetti A. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995;13:1377-1390.
16. Ishikawa S, Shibano Y, Asai Y, Kario K, Kayaba K, Kajh E. Blood pressure categories and cardiovascular risk factors in Japan: the Jichi Medical School (JMS) cohort study. Hypertens Res 2007;30:643-649.
17. Ferrara LA, Cardoni O, Mancini M, Zanchetti A. Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study. J Hum Hypertens 2007;21:795-801.
18. Hanninen MR, Niiranen TJ, Puukka PJ, Jula AM. Metabolic risk factors and masked hypertension in the general population: the Finn-Home study. J Hum Hypertens 2014;28:421-426.
19. Colantonio LD, Anstey DE, Carson AP, Ogedegbe G, Abdalla M, Sims M, et al. Metabolic syndrome and masked hypertension among African Americans: The Jackson Heart Study. J Clin Hypertens (Greenwich) 2017;19:592-600.
20. Mulè G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Palermo A, et al. Metabolic syndrome in subjects with white-coat hypertension: impact on left ventricular structure and function. J Hum Hypertens 2007;21:854-860.
21. Pierdomenico SD, Cuccurullo F. Ambulatory blood pressure monitoring in type 2 diabetes and metabolic syndrome: a review. Blood Press Monit 2010;15:1-7.
22. Liu X, Tao L, Cao K, Wang Z, Chen D, Guo J, et al. Association of highdensity lipoprotein with development of metabolic syndrome components: a five-year follow-up in adults. BMC Public Health 2015;15:412.
23. Yadav D, Lee ES, Kim HM, Choi E, Lee EY, Lim JS, et al. Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort. Atherosclerosis 2015;241:271-277.
24. Wang S, Liu K, Zhang X, Meng Q, Wang Y, Wan S, Chen X. Elevated resting heart rate predisposes metabolic syndrome in women rather than in men: a 15-year prospective study. BMC Cardiovasc Disord 2015;15:110.
25. Itani O, Kaneita Y, Tokiya M, Jike M, Murata A, Nakagome S, et al. Short sleep duration, shift work, and actual days taken off work are predictive life-style risk factors for new-onset metabolic syndrome: a sevenyear cohort study of 40, 000 male workers. Sleep Med 2017;39:87-94.
26. Takayama S, Takase H, Tanaka T, Sogiura T, Ohte N, Dohi Y. Smoking cessation without educational instruction could promote the development of metabolic syndrome. J Atheroscler Thromb 2018;25:90-97.
27. Chen YL, Hsu CH, Hsieh CH, Wu CZ, Lin JD, Chang JB, et al. High normotension is associated with future metabolic syndrome but not cardiovascular disease A 10-year longitudinal study. Medicine 2017;96:25.e7227.